Immunohistochemical staining revealed a significant decrease in CD31 expression in the SLC7A7 knockdown group, suggesting a reduction in tumor angiogenesis following SLC7A7 knockdown (Fig. 3F–H). The gene discussed is SLC7A7; the disease is neoplasm.